The 12-lead ECG hasn't changed in a century. The algorithms reading it have. Three CEOs and one educator on whether doctors ...
HeartSciences Inc. (Nasdaq: HSCS; HSCSW) (“HeartSciences” or the “Company”), a healthcare information technology (“HIT) ...
San Francisco-based AliveCor has received FDA clearance for two new algorithms for its smartphone-connected ECG: one that detects normality and one that detects interference. These follow up on ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award ...
AccurKardia, Inc., an ECG analytics software company focused on establishing ECG as a broad biomarker, today announced that ...
The developer of the one of the most widely used wearable ECG monitors has received clearance for two new algorithms that enable users to instantly know if their ECG readings are normal or possibly ...
The Food and Drug Administration has given clearance to AliveCor’s next generation of interpretive ECG algorithms, used in personal cardiology devices to support telemedicine. AliveCor’s KardiaMobile ...
Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered ...
Researchers at the Yale Cardiovascular Data Science (CarDS) Lab have developed an artificial intelligence (AI)-based model for clinical diagnosis that can use electrocardiogram (ECG) images, ...
Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology - the first of which is now commercially available “At Anumana, we are committed to developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results